Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CRISIL Ltd. Regulatory Filings 2021

Feb 22, 2021

58999_rns_2021-02-22_043e4fa4-e26c-4afc-96c2-f5567f32de3f.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [596 x 83] intentionally omitted <==

February 22, 2021

Listing Department National Stock Exchange of India Ltd. Exchange Plaza, 5[th] floor Plot No. C/1, G Block Bandra-Kurla Complex Bandra (East) Mumbai 400 051

Listing Department BSE Limited P J Towers Dalal Street Mumbai 400 001

Dear Sirs,

Sub.: Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015

We wish to inform you that pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Schedule of Analyst or Institutional Investor Meeting(s) with the Company is as under:

Date Type of Interaction Interaction with Venue
23-Feb-21 Elara Capital: BFSI Conference Several Funds/Investors Mumbai

Dates are subject to changes. Changes may happen due to exigencies on the part of investors/company.

Kindly take this communication on record and acknowledge receipt .

Yours faithfully,

For CRISIL Limited

==> picture [102 x 43] intentionally omitted <==

Minal Bhosale

Company Secretary

ACS 12999

CRISIL Limited

Corporate Identity Number: L67120MH1987PLC042363

Registered Office: CRISIL House, Central Avenue, Hiranandani Business Park, Powai, Mumbai - 400076. Phone: +91 22 3342 3000 | Fax: +91 22 3342 3001 www.crisil.com